Pre-filled pens
In the UK, meanwhile, supermarkets are spearheading the GLP-1 shift, aiming to tackle the decline in grocery expenditure by weight-loss drug users, whose bills have reduced by 2.2 percentage points more than non-users
Semaglutide is a GLP-1 agonist, Tirzepatide is a dual GLP-1/GIP (glucose-dependent insulinotropic polypeptide) agonist, and Retatrutide is a triple GLP-1/GIP/glucagon agonist
Short-acting formulations like exenatide (Byetta) clear within 1224 hours, while long-acting options such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) can take 45 weeks to fully eliminate
They do lead to weight loss on their own, but results are much better when paired with healthy eating and physical activity
A maintenance dose is typically 25 to 50% of the therapeutic dose